Granted Patent B2

US 12,576,251 · App. 18/105,668 · Granted Mar 17, 2026

Inventors: Blake Hedstrom (Minneapolis, MN); Shivanand P. Lad (Durham, NC); Aaron McCabe (Edina, MN); Emily Meyering (St. Louis Park, MN); Jack Mondry (Edina, MN); Amrita Sawhney (Princeton Junction, NJ); Elizabeth Scheurer (Minneapolis, MN); Matthew Stoll (Minneapolis, MN); Abhi Vase (Los Altos Hills, CA)

Assignee: PHARAOH NEURO, INC.

A61M27/006A61M2025/0031A61M2205/053A61M2205/054A61M2205/3344A61M2205/36A61M2205/50A61M2205/75A61M2230/005

Abstract

Claims (36)

1 . A system for treating cerebrospinal fluid, comprising:

a catheter assembly coupled a first fluid pathway for transporting a volume of cerebrospinal fluid from a patient to a filter and a second fluid pathway for returning filtered cerebrospinal fluid back to the patient;

a pump configured to withdraw the volume of cerebrospinal fluid from the patient and transfer the volume of cerebrospinal fluid to the filter along the first fluid pathway;

wherein the filter is configured to separate the volume of cerebrospinal fluid into a permeate and a retentate;

wherein the filter is configured to remove a target microorganism from the volume of cerebrospinal fluid such that the permeate is substantially free of the target microorganism; and

wherein the pump is configured to return at least a portion of the permeate to the patient along the second fluid pathway.

2 . The system of claim 1 , wherein the filter includes a tangential flow filter.

3 . The system of claim 1 , further comprising a sensor disposed adjacent to the filter.

4 . The system of claim 3 , wherein the sensor is configured to measure a characteristic of the volume of cerebrospinal fluid.

5 . The system of claim 4 , wherein the characteristic is a difference between a first flow rate along the first fluid pathway and a second flow rate along the second fluid pathway.

6 . The system of claim 4 , wherein the characteristic is a difference between a first fluid volume along the first fluid pathway and a second fluid volume along the second fluid pathway.

7 . The system of claim 4 , further comprising a processing unit coupled to the catheter assembly, the processing using being configured to increase a rate at which the volume of cerebrospinal fluid passes through the filter by diverting a diverted portion of the permeate or the retentate back through the filter.

8 . The system of claim 7 , wherein the processing unit is configured to update a parameter of a set of operation parameters based on the measured characteristic responsive to determining that the measured characteristic passes a predetermined threshold.

9 . The system of claim 1 , wherein the pump is configured to withdraw the volume of cerebrospinal fluid from the patient at a first flow rate and the pump is configured to return at least the portion of the permeate to the patient at a second flow rate different from the first flow rate.

10 . The system of claim 1 , further comprising an inactivating member coupled to the filter.

11 . The system of claim 10 , wherein the inactivating member includes a heating member.

12 . The system of claim 10 , wherein the inactivating member includes a cooling member.

13 . The system of claim 10 , wherein the inactivating member includes an ultraviolet radiation member.

14 . The system of claim 1 , wherein the target microorganism is a meningitis-related microorganism.

15 . A system for removing a target microorganism from cerebrospinal fluid, comprising:

a catheter assembly coupled a first fluid pathway and a second fluid pathway t;

a filter coupled to the catheter assembly;

wherein the filter is configured to separate a volume of cerebrospinal fluid withdrawing from a patient into a permeate and a retentate;

wherein the filter is configured to remove the target microorganism from the volume of cerebrospinal fluid; and

a pump configured to withdraw the volume of cerebrospinal fluid from the patient and transfer the volume of cerebrospinal fluid to the filter along the first fluid pathway and return at least a portion of the permeate to the patient along the second fluid pathway.

16 . The system of claim 15 , wherein the filter includes a tangential flow filter.

17 . The system of claim 15 , further comprising an inactivating member coupled to the filter.

18 . The system of claim 17 , wherein the inactivating member includes a heating member, a cooling member, an ultraviolet radiation member, or combinations thereof.

19 . The system of claim 15 , wherein the target microorganism is a meningitis-related microorganism.

20 . A system for treating cerebrospinal fluid, comprising:

a catheter assembly coupled a first fluid pathway for transporting a volume of cerebrospinal fluid from a patient to a filtration system coupled to the catheter assembly and a second fluid pathway for returning filtered cerebrospinal fluid back to the patient;

wherein the filtration system includes one or more tangential flow filters;

a pump configured to withdraw the volume of cerebrospinal fluid from the patient and transfer the volume of cerebrospinal fluid to the filtration system along the first fluid pathway;

wherein the filtration system is configured to separate the volume of cerebrospinal fluid into a permeate and a retentate;

wherein the filtration system is configured to remove a meningitis-related microorganism from the volume of cerebrospinal fluid; and

wherein the pump is configured the return the permeate to the patient along the second fluid pathway.

Assignments (4)

Continuity (4)

References Cited (400)